Heartsciences Inc. announced amendments to its bylaws, designating 4,285,714 shares as Series D Convertible Preferred Stock. Each share can be converted into one share of common stock, with no dividend except as declared by the Board. The Series D Preferred Stock ranks senior to common stock regarding dividend rights and rights upon liquidation.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-078404), on May 28, 2025, and is solely responsible for the information contained therein.